Lanthio Pharma's Series A Round

Lanthio Pharma raised a round of funding on November 27, 2012.

Lanthio Pharma is a biopharmaceutical company committed to developing and commercializing therapeutic peptides against difficult to target receptors (e.g. GPCRs). With its proprietary LanthioPep techn…

Articles about Lanthio Pharma's Series A Round: